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each professional group at each department adjusted to 
100,000 population. The data were grouped according to 
British Society for Rheumatology regions to study regional 
variations. The survey was completed by 164/167 depart-
ments (98% response rate). All departments reported an 
MDT comprising a rheumatologist (consultant or specialist 
trainee) and almost all included a specialist nurse but only 
28 (17%) of the departments had MDTs comprising all the 
professional groups. There was a high degree of regional 
variation in the provision of Allied Health Professionals 
(physiotherapists, occupational therapists, and podiatrists) 
in the UK. MDT care is recommended for the management 
of inflammatory arthritis, but few UK rheumatology depart-
ments have a full complement of healthcare professionals 
within their MDT. There is a high degree of regional vari-
ation in the composition and staffing levels of the rheuma-
tology MDT across the UK; the impact of which warrants 
further investigation.
Keywords Multidisciplinary · National survey · Arthritis · 
Health service · Rehabilitation · Team care
Introduction
The last two decades have seen dramatic developments in 
the management of rheumatic and musculoskeletal diseases 
(RMDs) mainly due to improvements in the diagnostic 
techniques, treatment strategies, and outcome measure-
ment. Patient care has shifted from a mainly in-patient to 
outpatient model, where the patients self-manage some 
aspects of their disease and have access to support from a 
diverse group of health professionals forming the multidis-
ciplinary team (MDT). This model of care is considered to 
represent the best clinical practice and is recommended by 
Abstract The objective of this study is to describe the com-
position of multidisciplinary teams (MDT) working within 
rheumatology departments across the UK. All rheumatol-
ogy departments in the United Kingdom (UK) were invited 
to participate in a national electronic survey between Feb-
ruary 2014 and April 2015 as a part of a national audit for 
the management of rheumatoid and early inflammatory 
arthritis commissioned by Healthcare Quality Improve-
ment Partnership. Rheumatology departments were asked 
to report their MDT composition; defined as a rheuma-
tologist (consultant or specialist trainee), specialist nurse, 
occupational therapist physiotherapist, and podiatrist. The 
data were collected as Whole Time Equivalent (WTE) of 
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the current treatment guidelines for inflammatory arthritis 
(IA) [1–3] and other long-term conditions [4–6].
MDT working can be defined as members of different 
health care professions with specialised skills and exper-
tise working together to support people with complex care 
needs [7]. In rheumatology services, the composition of the 
MDT would normally include a rheumatologist (a consult-
ant and/or a specialist registrar), a specialist nurse, a physi-
otherapist, an occupational therapist, and a podiatrist [3, 6, 
8]. However, there is a lack of consensus about the optimal 
configuration of the MDT in rheumatology services.
A recent meta-review investigating the effectiveness 
of MDT care in other long-term conditions (CHF, Diabe-
tes, COPD, and asthma) demonstrated benefits in clinical, 
functional, and patient-centred outcomes [9]. While some 
aspects of patient outcomes reported in the meta-review are 
important in rheumatology (improved function, quality of 
life, satisfaction with care, adherence to therapy, reduced 
readmissions, and mortality), the effectiveness of MDT 
working in rheumatology is unclear. Whilst there is evi-
dence to support the effectiveness of single disciplines in 
the management of specific patient groups [10–12], a sys-
tematic review of effectiveness of MDT care found limited 
evidence on disability, disease activity, or quality of life in 
people with rheumatoid arthritis (RA) [13]. The coordina-
tion of MDT care seems to be the key to its effectiveness 
[14]. Teams can be said to work at an ‘interdisciplinary’ 
level if working in a highly coordinated way with all team 
members working towards shared goals [14]. However, in 
the United Kingdom (UK), the composition of MDT in 
rheumatology is unknown and understanding the composi-
tion is important if interdisciplinary care is to be achieved.
The British Society for Rheumatology (BSR) conducted 
two national audits [15, 16] to assess the services available 
to patients when referred to rheumatology units with sus-
pected early inflammatory arthritis (IA). The audits were 
commissioned by the Healthcare Quality Improvement 
Partnership (HQIP) as part of the National Clinical Audit 
Programme. The first audit was conducted between Feb-
ruary 2014 and January 2015 and the second one between 
February 2015 and January 2016. We carried out an analy-
sis of the first audit data with additional data from the UK 
devolved nations, to study the composition of MDT within 
rheumatology departments in the UK.
Methods
Design
This was a cross-sectional descriptive study conducted by 
survey in all rheumatology departments within the UK. In 
England, the survey was a part of a broader national audit 
for rheumatoid and early inflammatory arthritis, commis-
sioned by HQIP [15]. As Scotland, Northern Ireland and 
the Channel Islands were not included in the HQIP audit, 
a separate but identical, service survey of all rheumatol-
ogy departments was conducted. Ethical approval was not 
required, but access to the data was granted by HQIP and 
supported by the BSR Research Committee and British 
Health Professionals in Rheumatology (BHPR).
Development of the survey content
A project working group was convened to design the sur-
vey content. This comprised senior clinicians and aca-
demics from several UK institutions, representatives from 
partner organisations and patient groups, working collabo-
ratively on behalf of the BSR and BHPR [15, 16]. The sur-
vey included organisation data regarding the specific inclu-
sion of, or direct access to, a rheumatologist, a specialist 
nurse, a physiotherapist, a podiatrist, and an occupational 
therapist as part of the MDT, including detail of their whole 
time equivalent (WTE) availability.
Data collection
Northgate Public Services, a software and outsourcing 
business, provided secure online databases and electronic 
audit tools which were made available to all rheumatol-
ogy units. Clinicians or administrators at each department 
uploaded their data securely onto the online database and 
the transferred to the MRC Lifecourse Epidemiology Unit, 
University of Southampton for analysis.
Statistical analysis
The staffing levels were measured in numbers of whole 
time equivalent (WTE) for each professional group. The 
data were analysed descriptively using STATA version 12.1 
for Windows, and summarised to determine the adjusted 
mean WTE and percentage of representation of each pro-
fessional group per 100,000-catchment population. Further 
grouping of the data according to BSR regions was used to 
show regional variations.
Results
The survey response rate was 98% with 164 out of 167 UK 
departments completing the survey. All MDTs managing 
IA include a physician (consultants and specialist trainees) 
and almost all include a specialist nurse. However, other 
allied health professional groups are not represented in all 
departments. For example, podiatrists are only available in 
48% of MDTs. Of the 164 surveyed departments, only 28 
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(17%) had access to a full MDT including a rheumatolo-
gist, a specialist nurse, a physiotherapist, an occupational 
therapist, and a podiatrist. The adjusted mean WTE per 
100,000 population ranged from 0.04 to 0.44 for rheuma-
tologists, 0.02–0.15 for rheumatology trainees, 0.05–0.44 
for specialist nurses, 0–0.7 for physiotherapists, 0.02–0.15 
for occupational therapists, and 0–0.04 for podiatrists (see 
Table 1).
Variation in the adjusted mean WTE availability of each 
professional group was notable when the BSR regions 
were considered. For example, the Northern Ireland had 
the highest adjusted mean WTE for rheumatologists, while 
London region had the lowest. For nurse specialists, North-
ern Ireland again had the highest adjusted mean WTE, 
while Scotland, London, South West and Yorkshire, and the 
Humber shared the lowest (Table 2). Northern Ireland had 
the lowest adjusted mean WTE for physiotherapists and 
the podiatrists (adjusted mean WTE for both professional 
groups was zero). These regional variations were evident 
across all professional groups and had no particular pattern. 
Figure 1 shows the regional variation in the (unadjusted) 
mean WTE staff levels across the UK. 
Discussion
The findings of this national survey provide recent informa-
tion regarding the inclusion of the five professional groups 
in rheumatology MDT. Despite being the cornerstone of 
the management of IA [3, 6], MDT provision in the UK is 
variable and, at times, only reaches the minimum definition 
for MDT care.
Our results show that all rheumatology departments have 
an MDT which comprises a rheumatologist and almost all 
have access to a nurse specialist but the inclusion of other 
allied healthcare professional groups is variable and podia-
trists, in particular, are poorly represented. Only 17% of the 
surveyed departments meet the current national guidance 
[3, 6] by having the five professional groups represented in 
their MDTs.
Our data clearly demonstrate that access to the three pro-
fessional groups (physiotherapists, occupational therapists, 
and podiatrists) is inadequate. Patients access these profes-
sional groups via three main routes: a referral by the gen-
eral practitioner (GP), the rheumatologist (consultant), or 
hospital in-patient services. In 2009, an audit of acute trusts 
found that only 73% of acute trusts provided access to 
physiotherapists, 64% to occupational therapist, and 55 to 
podiatrists [17]. For physiotherapy, a patient survey in 2011 
[18] revealed that 31% of patients had never been referred 
for physiotherapy. Among those who were referred, 32.2% 
waited for over 1 year to see a physiotherapist. Our data 
suggest that there was no improvement in the access to 
physiotherapists over four years and a little improvement in 
the access to occupational therapists. Our survey suggests 
that access to podiatrists by patients with RA is improving 
but is still poor despite national guidance [3, 6]. Previously, 
both an inception cohort [19] and the national survey [8] 
found that between 28 and 30% of patients with RA had 
access to a podiatrist.
While 99% of MDTs in our data have nurse specialist 
representation, we do not know if each centre has sufficient 
specialist nurses to meet the needs of patients. This is par-
ticularly important as the nursing staffing levels are linked 
with patient outcomes especially those related to initiation 
and escalation of treatments and monitoring of disease 
activity [10, 16]. However, we do not know the optimum 
staffing levels required to maximise patient benefit and this 
is an area for further research.
The high degree of regional variation in the provision of 
allied health professional services highlights the absence 
of some specialist services, such as physiotherapy, occu-
pational therapy, and podiatry, in some departments. For 
example, the two centres surveyed in Northern Ireland 
reported no access to a physiotherapist or podiatrist. In the 
national survey conducted in 2006 [8], Northern Ireland 
also reported no access to podiatry, which is concerning as 
there has been little change in service provision over the 
last decade, despite the publication of national management 
guidelines.
Identifying how MDTs meet the care needs of patients 
was beyond the scope of this study, but the regional vari-
ations and unavailability of some MDT services may have 
implications to patients’ care and outcomes. The natural 
Table 1  Overall rheumatology 
MDT staffing levels between 
professional groups
a
 Adjusted per 100,000 population
Profession Adjusted mean  WTEa SD Range Represented within MDT Y/N (%)
Consultants 0.08 1.64 0.04–0.44 164 (100)
Specialist trainee 0.02 0.28 0.02–0.15 132 (80)
Specialist nurses 0.08 1.89 0.05–0.44 162 (99)
Physiotherapists 0.03 0.85 0.00–0.70 120 (73)
Occupational therapists 0.03 0.85 0.02–0.15 123 (75)
Podiatrists 0.02 0.40 0.00–0.04 79 (48)
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Table 2  Variation in UK rheumatology staffing levels per region; values are reported as absolute mean and adjusted to per 100,000 population to account for variation in population size ser-
viced by each region
Region Number of 
departments
Total number of 
WTE staff
Mean WTE of 
all staff
Mean (and adjusted mean) WTE of individual professional groups
Consultants Specialist 
trainees
Nurse Special-
ists
Physiotherapists Occupational 
therapists
Podiatrists
East Midlands 7 116.02 4.71 Mean 3.91 1.36 7.97 2.34 1.52 1.50
Adjusted mean 0.11 0.04 0.21 0.06 0.04 0.04
East of England 14 142.76 4.93 Mean 3.26 1.61 2.43 1.24 1.28 1.54
Adjusted mean 0.24 0.04 0.06 0.03 0.03 0.04
London 23 290.74 4.00 Mean 3.87 1.71 4.75 3.09 2.14 0.74
Adjusted mean 0.04 0.02 0.05 0.03 0.02 0.01
North East 6 123.53 5.83 Mean 5.06 1.50 4.27 1.42 1.41 0.78
Adjusted mean 0.19 0.06 0.16 0.05 0.05 0.03
Northern Ireland 2 15.00 3.50 Mean 3.00 1.00 3.00 0.00 1.00 0.00
Adjusted mean 0.44 0.15 0.44 0.00 0.15 0.00
North West 17 157.77 5.69 Mean 3.11 1.16 3.39 1.76 1.40 1.10
Adjusted mean 0.05 0.02 0.06 0.03 0.02 0.02
Mersey 8 67.30 5.58 Mean 2.55 0.94 2.52 1.43 1.10 0.23
Adjusted mean 0.10 0.04 0.10 0.06 0.04 0.01
Scotland 11 101.19 5.09 Mean 3.32 0.87 2.05 1.24 1.17 0.72
Adjusted mean 0.07 0.02 0.05 0.03 0.03 0.02
South East 11 159.90 4.18 Mean 2.95 0.91 6.50 3.20 4.00 0.75
Adjusted mean 0.06 0.02 0.14 0.07 0.09 0.02
South Central 11 102.24 4.55 Mean 3.30 1.31 3.05 1.29 0.84 0.98
Adjusted mean 0.08 0.03 0.08 0.03 0.02 0.02
South West 15 139.86 5.67 Mean 2.95 0.97 2.46 1.18 1.20 0.67
Adjusted mean 0.06 0.02 0.05 0.02 0.02 0.01
Yorkshire and the 
Humber
14 183.45 5.36 Mean 4.09 1.33 2.98 1.61 2.25 0.99
Adjusted mean 0.06 0.02 0.05 0.03 0.04 0.02
Wales 11 175.30 4.82 Mean 9.02 0.91 2.68 2.12 1.15 1.05
Adjusted mean 0.28 0.03 0.08 0.07 0.04 0.03
West Midlands 14 204.30 5.50 Mean 4.19 1.24 6.45 1.36 0.94 0.50
Adjusted mean 0.07 0.02 0.11 0.02 0.02 0.01
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progression in IA is a decline in function and the evidence 
from several long-term conditions suggests that optimis-
ing MDT care promotes rehabilitation [14]. Inequitable 
access to MDT care could mean that some patients might 
be referred to general physiotherapy, occupational therapy, 
or podiatry services, which may not have specialist rheu-
matology knowledge. This could delay patient access to 
specialist management and affect patient outcomes and 
productivity. Our findings suggest that UK rheumatol-
ogy MDT composition may be more variable than in other 
Northern European countries. The study conducted by the 
Scandinavian Team Arthritis Register—European Team 
Initiative for Care Research (STAR-ETIC) collaboration 
[20] revealed large similarities in the composition of MDT 
teams across four Northern European countries (Sweden, 
The Netherlands, Denmark and Norway). Nine out of the 
10 Rheumatology centres investigated included a rheuma-
tologist, a nurse, a physiotherapist, an occupational thera-
pist and a social worker in their MDTs, although provision 
of podiatrists, psychologists, and nutritionists varied [20]. 
Fig. 1  Choropleth map showing the mean number of different health professions represented within a rheumatology department MDT by region
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However, the STAR-ETIC study [20] did not report the 
national picture of MDT provision in these countries there-
fore, whilst their findings are interesting, they are unlikely 
to be representative of MDT provision in Northern Europe. 
The UK national guidance recommends access to MDT [6] 
and our data provide good evidence of the extent to which 
this standard has been achieved nationally. Efforts can now 
be directed towards addressing inequitable access to the 
MDT.
Our study has two main limitations. First, our data pro-
vide only cross-sectional information on the availability 
of the professionals included in the rheumatology MDT 
within the UK. However, this information will be useful 
and act as a baseline for future studies. Second, our data do 
not inform the level of coordination or the interaction of the 
members within the MDTs. The national guidelines [3, 6] 
do not specify the proportion of professional representation 
or the level of coordination within the MDT. This study 
has determined the composition of the MDTs and future 
research is required to determine the optimal configuration 
and interaction of rheumatology MDT to inform practice 
and policy.
In conclusion, this study shows that over three-quarters 
of rheumatology teams in the UK do not have all recom-
mended professional groups represented in their MDTs 
thus fall short of the quality standards of care for people 
with IA. There is a high degree of regional variation in the 
composition and staffing levels of the rheumatology MDT 
and future studies should investigate the impact of these 
variations. Efforts should be directed towards improving 
equitable access to rheumatology specialist services to 
optimise outcomes for people with IA.
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